Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1994 1
1996 2
1997 1
1998 2
1999 1
2001 4
2003 2
2004 1
2006 1
2007 2
2008 2
2009 1
2010 4
2012 3
2013 1
2014 6
2015 2
2016 1
2017 4
2018 3
2019 1
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 4 Pharynx Mucositis or Stomatitis by Clinical Examination Classification, CTCAE"
Page 1
Otorhinolaryngological Toxicities of New Drugs in Oncology.
Hartl DM, Morel D, Saavedra E, Massard C, Rinaldo A, Saba NF, Ferlito A, Soria JC. Hartl DM, et al. Adv Ther. 2017 Apr;34(4):866-894. doi: 10.1007/s12325-017-0512-0. Epub 2017 Mar 17. Adv Ther. 2017. PMID: 28315206 Review.
Many new or relatively new cancer drugs-personalized anticancer agents-have been approved for use in various clinical settings in oncology or are still under evaluation in clinical trials. ...Adverse effects of the mouth/pharynx, nasal cavities, larynx, and c …
Many new or relatively new cancer drugs-personalized anticancer agents-have been approved for use in various clinical settings in onc …
Comprehensive risk evaluation for metachronous carcinogenesis after endoscopic submucosal dissection of superficial pharyngeal squamous cell carcinoma.
Ogasawara N, Kikuchi D, Tanaka M, Ochiai Y, Okamura T, Hayasaka J, Suzuki Y, Mitsunaga Y, Nomura K, Odagiri H, Yamashita S, Matsui A, Hoteya S. Ogasawara N, et al. Esophagus. 2022 Jul;19(3):460-468. doi: 10.1007/s10388-022-00907-8. Epub 2022 Jan 31. Esophagus. 2022. PMID: 35099639
The hemoglobin, albumin, lymphocyte, and platelet (HALP) score was analyzed as a serum marker. RESULTS: The median follow-up period was 4.3 years. The coincidence rate for pharyngeal and esophageal LVL grade was 55%. ...Pharyngeal LVL grade was superior to es …
The hemoglobin, albumin, lymphocyte, and platelet (HALP) score was analyzed as a serum marker. RESULTS: The median follow-up period was 4 …
Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants.
Nasuf AWA, Ojha S, Dorling J. Nasuf AWA, et al. Cochrane Database Syst Rev. 2018 Sep 7;9(9):CD011921. doi: 10.1002/14651858.CD011921.pub2. Cochrane Database Syst Rev. 2018. PMID: 30191961 Free PMC article. Review.
We performed the last search in August 2017. We contacted trial investigators regarding unpublished studies and data. SELECTION CRITERIA: We searched for published and unpublished randomised controlled trials comparing early administration of oropharyngeal colostrum …
We performed the last search in August 2017. We contacted trial investigators regarding unpublished studies and data. SELECTION CRITE …
Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A, Villar RC, de Castro G Jr, Antequera R, Gil E, Rosalmeida MC, Federico MH, Snitcovsky IM. Gouvêa de Lima A, et al. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):270-5. doi: 10.1016/j.ijrobp.2010.10.012. Epub 2010 Dec 14. Int J Radiat Oncol Biol Phys. 2012. PMID: 21163585 Clinical Trial.
The secondary endpoints included patient-reported pain scores. To detect a decrease in the incidence of Grade 3 or 4 oral mucositis from 80% to 50%, we planned to enroll 74 patients. ...The mean delivered radiation dose was greater in the patients treated wit …
The secondary endpoints included patient-reported pain scores. To detect a decrease in the incidence of Grade 3 or 4 oral m …
Dysphagia following chemoradiation for locally advanced head and neck cancer.
Nguyen NP, Moltz CC, Frank C, Vos P, Smith HJ, Karlsson U, Dutta S, Midyett FA, Barloon J, Sallah S. Nguyen NP, et al. Ann Oncol. 2004 Mar;15(3):383-8. doi: 10.1093/annonc/mdh101. Ann Oncol. 2004. PMID: 14998839 Free article. Review.
Modified barium swallow (MBS) studies were performed if the patients complained of dysphagia or if there was clinical suspicion of aspiration. The severity of dysphagia was graded on a scale of 1-7. ...Among 33 patients who underwent MBS following treatment, 12 pati …
Modified barium swallow (MBS) studies were performed if the patients complained of dysphagia or if there was clinical suspicion of as …
Definitive Intensity-modulated Radiation Therapy in Elderly Patients with Locally Advanced Oropharyngeal Cancer.
DE Felice F, Galdieri A, Abate G, Bulzonetti N, Musio D, Tombolini V. DE Felice F, et al. In Vivo. 2017 May-Jun;31(3):455-459. doi: 10.21873/invivo.11083. In Vivo. 2017. PMID: 28438879 Free PMC article.
All patients completed programmed IMRT treatment, without any reduction of total dose. Oral pain and mucositis were the most common acute side-effects, classified as grade 3 in 6 patients (40%) only. ...Due to age and comorbidity, no dose or volume reduction for IMR …
All patients completed programmed IMRT treatment, without any reduction of total dose. Oral pain and mucositis were the most common a …
Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck.
Andrä C, Rauch J, Li M, Ganswindt U, Belka C, Saleh-Ebrahimi L, Ballhausen H, Nachbichler SB, Roeder F. Andrä C, et al. Radiat Oncol. 2015 Jul 10;10:140. doi: 10.1186/s13014-015-0449-x. Radiat Oncol. 2015. PMID: 26156022 Free PMC article.
Only two of the four deaths were sarcoma related. Maximum acute toxicity (CTCAE 3.0) was grade 1 in 27 % of the patients, grade 2 in 50 % and grade 3 in 23 %. Severe acute toxicity was mainly represented by mucositis and dysphagia. Maximum late …
Only two of the four deaths were sarcoma related. Maximum acute toxicity (CTCAE 3.0) was grade 1 in 27 % of the patients, g …
Evaluation of Pharyngeal Background Mucosa in Patients with Superficial Hypopharyngeal Carcinoma.
Kimura Y, Watanabe A, Shimizu Y, Goda K, Ito S, Nishimura Y, Inoue M, Taniguchi M. Kimura Y, et al. Laryngoscope. 2021 Sep;131(9):2036-2040. doi: 10.1002/lary.29524. Epub 2021 Mar 17. Laryngoscope. 2021. PMID: 33729575
Endoscopic images were reviewed in a blinded fashion by two endoscopists. LVLs in the pharyngeal mucosa were graded as follows: A, no lesions; B, 1 to 4 lesions; and C, 5 lesions per endoscopic view. RESULTS: Cumulative incidence curves of secondary HNSCC in the gro …
Endoscopic images were reviewed in a blinded fashion by two endoscopists. LVLs in the pharyngeal mucosa were graded as follows: A, no …
Effects of N-acetyl-cysteine and acetylsalicylic acid on the tonsil bacterial biofilm tissues by light and electron microscopy.
Bulut F, Meric F, Yorgancilar E, Nergiz Y, Akkus M, Nergiz S, Nasir Y. Bulut F, et al. Eur Rev Med Pharmacol Sci. 2014;18(23):3720-5. Eur Rev Med Pharmacol Sci. 2014. PMID: 25535147 Free article.
Based on studies that have shown the presence of biofilms in common sites of chronic infections, it has become clear that bacteria may persist on mucosal surfaces through formation of biofilms. PATIENTS AND METHODS: Ten patients between 4 and 39 years of age (mean, …
Based on studies that have shown the presence of biofilms in common sites of chronic infections, it has become clear that bacteria may persi …
Evaluation of purely accelerated six fractions per week radiotherapy in postoperative oral cavity squamous cell carcinoma.
Rath S, Khurana R, Sapru S, Rastogi M, Gandhi AK, Hadi R, Sahni K, Mishra SP, Srivastava AK, Syedkather F. Rath S, et al. Asia Pac J Clin Oncol. 2020 Feb;16(1):14-22. doi: 10.1111/ajco.13244. Epub 2019 Dec 2. Asia Pac J Clin Oncol. 2020. PMID: 31793206 Clinical Trial.
Primary endpoint was to assess acute toxicity, which was reviewed weekly during RT using Radiation Therapy Oncology Group criteria. RESULTS: Maximal grade 3 oral mucositis, pharynx/esophageal toxicity, and skin toxicity were seen in 77.5%, 25%, and 17.5%, res …
Primary endpoint was to assess acute toxicity, which was reviewed weekly during RT using Radiation Therapy Oncology Group criteria. RESULTS: …
45 results